Medicine Supply Notification: Oxybutynin (Kentera® ) 3.9mg/24hours transdermal patches
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin (Kentera®) 3.9mg/24hours transdermal patches. MSN/2026/004 Tier 2 – Medium impact Date of issue: 28 January 2026 Oxybutynin (Kentera®) 3.9mg/24hours transdermal patches are out of stock until late-February 2026. Oxybutynin 5mg and 10mg modified-release tablets remain available and can support increased [...]
The post Medicine Supply Notification: Oxybutynin (Kentera® ) 3.9mg/24hours transdermal patches appeared first on Community Pharmacy England.
Recent Comments